StockData

IRulya Therapeutics Inc. (IRLA) stock

IRLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$38.45+1.09 (+2.92%)

Close on Nov 17, 2026Market cap $39.11MP/E –Yield –

IRulya Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

IRulya Therapeutics's market cap was $38.98M on Nov 11, 2026, against $3.98B a year earlier. Over the last 5 years it ranged from $5.57M to $7.54B, with a median of $951.79M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$38.98M-98.9%
2025Dec 31, 2025$3.65B+125.6%
2024Dec 31, 2024$1.62B+112.1%
2023Dec 29, 2023$763.22M+65.7%
2022Dec 30, 2022$460.59M-93.9%
2021Dec 31, 2021$7.54B-54.0%
2020Dec 31, 2020$16.39B-45.6%
2019Dec 31, 2019$30.14B–

More IRulya Therapeutics figures

See a number that looks wrong?